Trademark: 90492029
Word
ZORDOBA
Status
Pending
Status Code
734
Status Date
Tuesday, February 20, 2024
Serial Number
90492029
Mark Type
4000
Filing Date
Thursday, January 28, 2021
Published for Opposition
Tuesday, June 29, 2021

Trademark Owner History
Novartis AG - Owner At Publication

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
The wording "ZORDOBA" has no meaning in a foreign language.

Trademark Events
Feb 21, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 20, 2024
Sou Extension 5 Granted
Feb 20, 2024
Sou Extension 5 Filed
Feb 20, 2024
Sou Teas Extension Received
Aug 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 5, 2023
Sou Extension 4 Granted
Aug 5, 2023
Sou Extension 4 Filed
Aug 5, 2023
Sou Teas Extension Received
Feb 23, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 21, 2023
Sou Extension 3 Granted
Feb 21, 2023
Sou Extension 3 Filed
Feb 21, 2023
Sou Teas Extension Received
Aug 26, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 24, 2022
Sou Extension 2 Granted
Aug 24, 2022
Sou Extension 2 Filed
Aug 24, 2022
Sou Teas Extension Received
Feb 24, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 22, 2022
Sou Extension 1 Granted
Feb 22, 2022
Sou Extension 1 Filed
Feb 22, 2022
Sou Teas Extension Received
Aug 24, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 29, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 29, 2021
Published For Opposition
Jun 9, 2021
Notification Of Notice Of Publication E-Mailed
May 27, 2021
Approved For Pub - Principal Register
May 27, 2021
Assigned To Examiner
Apr 28, 2021
New Application Office Supplied Data Entered
Feb 1, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24